The Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...
Zacks.com on MSN1mon
GSK Beats on Q4 Earnings & Sales, Stock Up on Raised Long-Term OutlookSales of the influenza vaccine, Fluarix, rose 14%. Sales of Established vaccines improved 8%. During the quarter, GSK did not ...
Zacks.com on MSN24d
Glaxo (GSK) Up 8% Since Last Earnings Report: Can It Continue?Sales of the influenza vaccine, Fluarix, rose 14%. Sales of Established vaccines improved 8%. During the quarter, GSK did not record any sales from the COVID-19 booster vaccine co-developed in ...
The mRNA-1083 generated an equivalent or better immunological response compared to current flu vaccines, matching GSK’s Fluarix Quadrivalent in adults aged 50 to 64 and outperforming Sanofi’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback